STAT3 and head and neck cancer: In addition to its important role in oncogenesis, STAT3 is also involved in modeling of cancer stem cells (CSCs) of various origins, including breast, lung, pancreas, and head and neck cancers [11–15], suggesting that STAT3 inhibition is an approach to enhancing CSC-targeted therapy in human cancers.